Tildacerfont in Adults with Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies

Article

Abstract: Context: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHD) is typically treate

Palabras claves:

17-hydroxyprogesterone, adrenocorticotropic hormone, androstenedione, Congenital adrenal hyperplasia, CRF-receptor antagonist, tildacerfont

Autores:

Barnes C.N., Huang M., Imel E.A., Madu I.J., Merke D.P., Moriarty D., Nakhle S., Newfield R.S., Richard J. Auchus, Sarafoglou K., Vogiatzi M.G.

Fuentes:

scopus